InterMed Discovery GmbH Company Profile

19:52 EST 19th December 2014 | BioPortfolio

InterMed Discovery is a world class natural product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated natural product discovery engines, InterMed Discovery generates proprietary product pipelines of functional ingredients and also supports partners in research and lead generation. Biologically characterised product leads are identified using IMD BIOPROFILING® and NPSilico®, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on natural products. InterMed Discovery adds to this the industry’s largest collections of pure compounds, sample fractions and mixtures as its source for potential natural product leads. The Company is located in Dortmund, Germany and was founded in 2006 as a management buyout of the Natural Products Research Unit of Bayer Healthcare. IMD entered into strategic cooperations with companies such as Cognis GmbH (now BASF SE) and Biotropics Malaysia Berhad. Further information on InterMed Discovery can be found at

News Articles [372 Associated News Articles listed on BioPortfolio]

C4X Discovery nets £10mm in IPO on AIM

Small-molecule drug discovery and design optimization firm C4X Discovery Holdings PLC netted £10mm ($16.1mm) in an initial public offering of 11mm shares at £1.00 apiece on London’s AIM Exchange. ...

Sygnature Discovery Celebrates its 10th Birthday with a Symposium on Aspects of Modern Drug Discovery

Sygnature Discovery, the United Kingdom’s largest independent provider of integrated drug discovery resource and expertise, celebrated its 10th anniversary by hosting a symposium on “Aspects of Mo...

AstraZeneca signs drug discovery collaboration with Cancer Research UK

UK pharma major AstraZeneca and charity Cancer Research UK have signed a memorandum of understanding through which Cancer Research UK drug discovery investigators would be given access to state-of-the...

Sygnature Discovery to Celebrate 10th Anniversary with Symposium on ‘Aspects of Modern Drug Discovery’

BioCity-based, Sygnature Discovery is marking its tenth year in business this October with a symposium to celebrate world-class science.

The Current issue of “The view from here” discusses allosterism in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is allosterism in drug discovery.

Discovery stage in pharma and biotech partnering – Trends from 2009 to 2014

Numerous pharma and biotech partnering deals have been signed at the discovery stage over the past few years; discovery stage deals remain the most popular stage at which deals are announced. Discover...

Evotec, Fraunhofer In Joint Discovery Alliance

Expands Evotec's drug discovery platform

Table 1: Adjuvant discovery contracts

Cover Story: Boosting adjuvants Table 1. Adjuvant discovery contracts. The NIH has awarded contracts totaling more than $70 million for 7 new adjuvant discovery projects. Amounts shown represent the p...

PubMed Articles [500 Associated PubMed Articles listed on BioPortfolio]

ONU discovery using multiple subchannels for seamless service support in long-reach OFDMA-PON.

In a passive optical network (PON), discovery is a process that detects and registers newly connected optical network units (ONUs). A long-reach PON requires a longer discovery window, e.g., at least ...

Antimalarial Drug Discovery: From Quinine to the Dream of Eradication.

The search for antimalarial remedies predates modern medicine and the concept of small molecule chemotherapy, yet has played a central role in the development of both. This history is reviewed in the ...

Simulation of Swanson's Literature-Based Discovery: Anandamide Treatment Inhibits Growth of Gastric Cancer Cells In Vitro and In Silico.

Swanson's literature-based discovery focus on resurrecting previously published but neglected knowledge. In this study, we propose a two-step model of the discovery process and generate a hypothesis b...

Efficient approach to discover novel agrochemical candidates: Intermediate Derivatization Method.

Intensive competition of intellectual property, easy development of agrochemical resistance and more strict regulations of environmental concerns make the successful rate for agrochemical discovery ex...

Recent advances in natural product discovery.

Natural products have been and continue to be the source and inspiration for a substantial fraction of human therapeutics. Although the pharmaceutical industry has largely turned its back on natural p...

Clinical Trials [43 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial

Background: somatic patients with psychiatric co-morbidities are a major challenge for the health care system. This study evaluated a psychiatric intervention targeted at the complex medic...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Study Vitamin D in Healthy Individuals

To obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting specimens from healthy subjects t on vitamin D assays, and to esta...

Biomarker Discovery and Validation in Lung Cancer

Lung cancer is responsible for the most deaths due to cancer each year in both men and women worldwide and once diagnosed, the 10 year survival rate is poor (

Companies [1001 Associated Companies listed on BioPortfolio]

InterMed Discovery GmbH

InterMed Discovery is a world class natural product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and co...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including, as well as its Continuing Medical Education (CME) business and ...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

Med Discovery SA

Med Discovery’s mission is the discovery and development of highly specific protein drugs to treat uro-genital cancers. By combining biological drug discovery expertise with a strong in-house knowle...

More Information about "InterMed Discovery GmbH" on BioPortfolio

We have published hundreds of InterMed Discovery GmbH news stories on BioPortfolio along with dozens of InterMed Discovery GmbH Clinical Trials and PubMed Articles about InterMed Discovery GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InterMed Discovery GmbH Companies in our database. You can also find out about relevant InterMed Discovery GmbH Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record